PXAI Audio Feed
29/03 08:54 defenseworld.net

Chardan Capital Reaffirms “Buy” Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)

Rocket PharmaceuticalsChardan Capitalbuy ratingprice targetbiotechWall Street Zen
28/03 08:54 defenseworld.net

BTIG Research Reiterates “Buy” Rating for Ovid Therapeutics (NASDAQ:OVID)

Ovid TherapeuticsBTIG Researchbuy ratingtarget priceWeiss RatingsHC Wainwright
27/03 07:10 defenseworld.net

What is Lifesci Capital’s Forecast for Surrozen Q1 Earnings?

SurrozenLifesci CapitalQ1 EPS forecastnegative earningsfinancial analysisNASDAQ:SRZN
20/03 08:22 defenseworld.net

Research Analysts Set Expectations for EPRX FY2026 Earnings

Eupraxia PharmaceuticalsFY2026 earningsanalyst downgradeStrong‑BuyStrong‑Sellprice target
19/03 08:06 defenseworld.net

Tarsus Pharmaceuticals (NASDAQ:TARS) Upgraded at Lifesci Capital

Tarsus PharmaceuticalsLifesci CapitalOppenheimerWeiss RatingsWall Street ZenEPS forecast
19/03 07:16 defenseworld.net

What is Lifesci Capital’s Estimate for Savara Q2 Earnings?

Savara IncLifesci CapitalQ2 earningsEPS forecastbuy ratingprice target
18/03 11:02 defenseworld.net

Tenax Therapeutics (NASDAQ:TENX) Now Covered by Cantor Fitzgerald

Tenax TherapeuticsCantor FitzgeraldGuggenheimWeiss RatingsLifesci CapitalWilliam Blair
16/03 07:48 defenseworld.net

What is Lifesci Capital’s Forecast for TENX Q1 Earnings?

Tenax TherapeuticsQ1 earningsLifesci Capitalstrong buyfull‑year forecastWilliam Blair
15/03 08:32 defenseworld.net

Prime Medicine (NASDAQ:PRME) Research Coverage Started at Oppenheimer

Prime MedicinePRMEOppenheimerLifesci Capitalanalyst ratingsoutperform
15/03 08:32 defenseworld.net

Prime Medicine (NASDAQ:PRME) Research Coverage Started at Oppenheimer

Prime MedicinePRMEOppenheimerLifesci Capitalanalyst ratingsoutperform
Comments
Loading...
0